United States · Series B startup

Who invested in Allyx Therapeutics

3 rounds we have observed, with the 2 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Biotech

Raised 6 months ago

Funding summaryUpdated 26 Oct 2026

$33Mraised across 3 rounds since 2024, from 3 sources

$3.3MGrant$3.3MRound$27MSeries B
Latest round
Series B, $27MMay 2026
Step-upi
8×
Investors
2
See who backed them

The funding story

Each circle is a round, placed by date and sized by amount. The line above is the running total.

20252026
$3.3MGrant$3.3MRound$27MSeries B
First round
Grant, $3.3M
Oct 2024
Biggest round
$27M
Series B · May 2026
Usual gap between rounds
17 months
the median of 2

The rounds

  1. May 2026
    Series B$27M2 returning

    Source recordedSEC filing: $26M sold

  2. Feb 2026
    Round$3.3M

    No investor was named in the report.

    Filed with the SEC (Form D); no report of this raise yetSEC filing: $3.3M sold, first sale Feb 2026

  3. Oct 2024

Founders and team

From Allyx Therapeutics's own website: 1 on the team.

  • Patrick SimmsVP Clinical Operations

Who was in which round

The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.

Everyone who backed them

Missing a round, or an investor who was in one? Tell us.

Quick answers about Allyx Therapeutics

Who invested in Allyx Therapeutics?

Allyx Therapeutics's investors include National Institutes of Health and Connecticut Innovations.

How much has Allyx Therapeutics raised?

Allyx Therapeutics has raised $33M across 3 rounds since 2024.

When did Allyx Therapeutics last raise?

Allyx Therapeutics's most recent round was a Series B of $27M in May 2026.

What was Allyx Therapeutics's biggest round?

Its most recent round, $27M in May 2026, is also its largest on record.

Who backed Allyx Therapeutics first?

Allyx Therapeutics's first round on record, in Oct 2024, was backed by National Institutes of Health and Connecticut Innovations.

What stage is Allyx Therapeutics at?

Allyx Therapeutics's latest named round is a Series B, in May 2026.

Where is Allyx Therapeutics based?

Allyx Therapeutics is based in the United States.

Companies like Allyx Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.